Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (''draw-back'' therapy)

Author： Tahara M.   Matsuoka T.   Yokoi T.   Tasaka K.   Kurachi H.   Murata Y.  

Publisher： Elsevier

ISSN： 0015-0282

Source： Fertility and Sterility, Vol.73, Iss.4, 2000-04, pp. : 799-804

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A prospective randomized comparison of routine buserelin acetate and a decreasing dosage of nafarelin acetate with a low-dose gonadotropin-releasing hormone agonist protocol for in vitro fertilization and intracytoplasmic sperm injection

By Takeuchi S.   Minoura H.   Shibahara T.   Tsuiki Y.   Noritaka F.   Toyoda N.  

Fertility and Sterility, Vol. 76, Iss. 3, 2001-09 ,pp. : 532-537

Elsevier

Access to resources Recommend Favorite

Gonadotropin-releasing hormone agonist plus ''add-back'' hormone replacement therapy for treatment of endometriosis: a prospective, randomized, placebo-controlled, double-blind trial

By Franke H.R.   van de Weijer P.H.M.   Pennings T.M.M.   van der Mooren M.J.  

Fertility and Sterility, Vol. 74, Iss. 3, 2000-09 ,pp. : 534-539

Elsevier

Access to resources Recommend Favorite

Combined use of a long-acting gonadotropin-releasing hormone agonist and low-dose danazol in advanced stage endometriosis

By Ugur M.   Senoz S.   Gokmen O.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 68, Iss. 1, 1996-09 ,pp. : 155-158

Elsevier

Access to resources Recommend Favorite

Effective treatment of severe menstrual migraine headaches with gonadotropin-releasing hormone agonist and &unknown;add-back&unknown; therapy

By Murray S.C.   Muse K.N.  

Fertility and Sterility, Vol. 67, Iss. 2, 1997-02 ,pp. : 390-393

Elsevier

Access to resources Recommend Favorite

Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis

By Surrey E.S.   Silverberg K.M.   Surrey M.W.   Schoolcraft W.B.  

Fertility and Sterility, Vol. 78, Iss. 4, 2002-10 ,pp. : 699-704

Elsevier

Access to resources Recommend Favorite